Krzysztof Jamroziak

10PUBLICATIONS
78CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMedical bacteriologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 10, 2026
Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

|May 12, 2026
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis.

|Jan 27, 2025
Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax-based regimens: A real-world analysis of Polish Adult Leukemia Group (PALG).

Elżbieta Kalicińska, Paula Jablonowska-Babij, Marta Morawska

|Jan 03, 2025
Update on B-cell maturation antigen-directed therapies in AL amyloidosis.

Krzysztof Jamroziak, Klaudia Zielonka, Jahanzaib Khwaja

|Nov 27, 2024
Measurable Residual Disease in Hematological Cancers.

Krzysztof Jamroziak, Bartosz Puła

|May 07, 2024
Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma.

Tadeusz Kubicki, Dominik Dytfeld, David Barnidge

Pageof 2

Frequent Collaborators

4 joint publications

Bartosz Puła

2 joint publications

Anna Łojko-Dankowska

2 joint publications

Łukasz Szukalski

2 joint publications

Agata Tyczyńska